Nuclear Medicine Equipment Market Size & Growth Forecast 2027–2036, By Segments (Type, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Nuclear Medicine Equipment Market size was worth USD 7.46 billion in 2026 and is expected to grow at a 2.95% CAGR between 2027 and 2036, reaching USD 9.98 billion by 2036. The industry revenue for 2027 is assessed at USD 7.65 billion.
Get more details on this report
Request Free Sample ReportNuclear Medicine Equipment Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to its established imaging infrastructure, broad installed equipment base, consistent clinical utilization, and ongoing replacement demand for advanced systems that enhance diagnostic precision and workflow efficiency.
- Asia Pacific is forecast to expand at a 3.65% CAGR, driven by hospital modernization, wider access to advanced diagnostic services, and increasing installation of imaging equipment across expanding healthcare networks.
Segment Momentum
- SPECT led the market in 2026 because of its broad installed base and routine use across established diagnostic workflows, providing dependable imaging capacity for everyday nuclear medicine procedures.
- Diagnostic imaging centers are expanding fastest as healthcare providers seek efficient outpatient imaging services that improve scheduling, patient throughput, and access to specialized nuclear medicine procedures.
Market Expansion Drivers
- Rising prevalence of cancer and cardiovascular diseases increasing demand for advanced molecular imaging systems.
- Growing clinical trial activity and drug discovery investments supporting nuclear imaging equipment utilization.
- Increasing adoption of targeted radiotherapy enhancing demand for precision nuclear medicine technologies.
Leading Market Participants
- Major companies in the nuclear medicine equipment market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Mediso Ltd. (Hungary), Neusoft Medical Systems Co., Ltd. (China), Bracco Imaging S.p.A. (Italy), CMR Naviscan Corporation (United States), Shenzhen Anke High-tech Co., Ltd. (China), Spectrum Dynamics Medical Ltd. (Israel).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 7.46 billion
- 2027 Estimated Market Size: USD 7.65 billion.
- Projected Market Size: USD 9.98 billion by 2036
- Growth Forecast: 2.95% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: SPECT (Type) | Hospital (End Use) | Oncology (Application)
- Emerging Opportunity Segment: PET (Type) | Diagnostic Imaging Centers (End Use) | Oncology (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of cancer and cardiovascular diseases increasing demand for advanced molecular imaging systems
The nuclear medicine equipment market is being supported by the growing need to diagnose and evaluate cancer and cardiovascular diseases through advanced molecular imaging approaches. As clinical demand for disease assessment increases, healthcare providers require imaging systems capable of providing detailed information about biological processes and disease activity. This is encouraging investment in nuclear medicine equipment that supports more specialized diagnostic workflows and improves the availability of molecular imaging capabilities.
Growing clinical trial activity and drug discovery investments supporting nuclear imaging equipment utilization
Expansion of clinical research and investment in drug discovery is creating broader applications for nuclear imaging technologies beyond routine diagnostic use. The nuclear medicine equipment market will benefit as research organizations and healthcare settings require imaging capabilities to evaluate therapies and study biological responses during clinical development. Greater utilization across research-oriented workflows is increasing the role of nuclear imaging equipment in supporting therapeutic investigation and drug development activities.
Increasing adoption of targeted radiotherapy enhancing demand for precision nuclear medicine technologies
The increasing use of targeted radiotherapy is creating demand for nuclear medicine technologies that support more precise approaches to treating disease. For the nuclear medicine equipment market, this shift is strengthening the need for systems capable of supporting accurate imaging and treatment-related workflows associated with targeted applications. Greater clinical emphasis on precision is encouraging healthcare providers to adopt equipment that can facilitate the integration of advanced nuclear medicine techniques into specialized treatment pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of cancer and cardiovascular diseases increasing demand for advanced molecular imaging systems | 1.90% | High | North America, Europe | High | Near Term |
| Growing clinical trial activity and drug discovery investments supporting nuclear imaging equipment utilization | 1.60% | High | North America, Asia Pacific | Medium | Mid Term |
| Increasing adoption of targeted radiotherapy enhancing demand for precision nuclear medicine technologies | 1.40% | High | Europe, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the nuclear medicine equipment market in 2026, supported by advanced healthcare infrastructure, widespread access to specialized imaging services, and established capabilities in nuclear medicine diagnosis and treatment. The region benefits from strong demand for sophisticated diagnostic equipment used in oncology, cardiology, neurology, and other specialized applications. Increasing emphasis on early and precise disease detection is encouraging healthcare providers to adopt advanced imaging technologies, while improvements in hybrid imaging and radiopharmaceutical-based procedures are expanding clinical applications. Established specialist training and healthcare investment further reinforce the region's ability to integrate advanced nuclear medicine technologies.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, supported by expanding healthcare infrastructure, increasing prevalence of chronic diseases, and improving access to advanced diagnostic technologies. Rising investment in hospitals and specialized medical centers is enabling broader deployment of nuclear medicine equipment, particularly in developing healthcare systems. Growing awareness of early disease detection and the increasing use of advanced imaging for cancer and cardiovascular care are strengthening demand. Improvements in radiopharmaceutical availability, specialist capabilities, and healthcare access are also helping expand the use of nuclear medicine technologies across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic InvestmentGermany emphasizes advanced nuclear medicine technologies that strengthen clinical imaging quality and operational reliability. Hospitals invest in equipment supporting hybrid imaging, efficient workflows, and integration with specialized oncology and cardiology services.
France 🇫🇷
Oncology Imaging FocusFrance prioritizes nuclear medicine equipment that supports expanding oncology diagnostics and therapeutic monitoring. Healthcare providers seek reliable imaging platforms capable of improving workflow efficiency while meeting evolving clinical standards.
Italy 🇮🇹
Hospital Equipment RenewalItaly is gradually renewing nuclear medicine equipment to enhance diagnostic capabilities across regional healthcare networks. Investment focuses on modern imaging systems that improve patient throughput, image quality, and compatibility with multidisciplinary care pathways.
Japan 🇯🇵
Aging Care DiagnosticsJapan expands nuclear medicine equipment deployment to improve diagnosis and treatment planning for age-related diseases. Healthcare facilities prioritize compact, efficient imaging systems that enhance clinical productivity while supporting specialized patient care.
South Korea 🇰🇷
Clinical Technology IntegrationSouth Korea continues integrating advanced nuclear medicine equipment with digital healthcare infrastructure to improve diagnostic precision. Hospitals focus on technologies that optimize imaging performance, support personalized treatment planning, and streamline clinical operations.
United States 🇺🇸
Advanced Imaging InfrastructureThe U.S. continues upgrading nuclear medicine equipment to support precision diagnostics and targeted therapies. Healthcare providers prioritize systems offering higher imaging accuracy, workflow efficiency, and compatibility with expanding radiopharmaceutical applications.
Segment Leadership and Growth Trends
Nuclear Medicine Equipment Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: SPECT (Largest Segment) vs PET (Fastest-Growing Segment)
SPECT dominated the nuclear medicine equipment market with the largest share in 2026, supported by its broad use in routine diagnostic imaging and functional assessment across healthcare settings. Its established clinical role in cardiac, neurological, and bone imaging, combined with widespread familiarity among healthcare professionals, supports sustained equipment adoption. The ability of SPECT systems to provide functional information alongside anatomical imaging makes them valuable for disease detection, treatment planning, and ongoing patient evaluation.
PET is gaining stronger adoption as healthcare providers place greater emphasis on advanced molecular and metabolic imaging. Its ability to identify physiological changes at an earlier stage supports applications in oncology, neurology, and cardiology, while increasing demand for personalized diagnostic approaches is encouraging broader utilization. Expanding access to specialized imaging services and greater integration of advanced diagnostic technologies are further strengthening the growth prospects of the PET segment.
End Use Segment Analysis: Hospital (Largest Segment) vs Diagnostic Imaging Centers (Fastest-Growing Segment)
In the nuclear medicine equipment market, the hospital end-use segment held the largest share in 2026, reflecting the concentration of complex diagnostic and therapeutic services within hospital-based facilities. Hospitals require nuclear medicine systems to support comprehensive patient evaluation across oncology, cardiology, neurology, and other specialties. Their integrated infrastructure, availability of specialized clinical personnel, and ability to manage complex diagnostic workflows continue to reinforce hospital-based demand.
Diagnostic imaging centers are emerging as an important growth channel as healthcare delivery increasingly shifts toward specialized and outpatient diagnostic services. These facilities benefit from focused imaging workflows, shorter patient turnaround times, and increasing demand for accessible advanced diagnostics outside traditional hospital environments. Greater specialization in nuclear imaging and expanding use of non-invasive diagnostic procedures are supporting wider deployment within independent and dedicated imaging facilities.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | SPECT, PET, Planar Scintigraphy Systems | SPECT | PET |
| End Use | Hospital, Diagnostic Imaging Centers, Others | Hospital | Diagnostic Imaging Centers |
| Application | Oncology, Cardiology, Neurology, General Imaging | Oncology | Oncology |
Competitive Landscape and Market Positioning
Top players in the nuclear medicine equipment market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Mediso Ltd. (Hungary)
6. Neusoft Medical Systems Co. Ltd. (China)
7. Bracco Imaging S.p.A. (Italy)
8. CMR Naviscan Corporation (United States)
9. Shenzhen Anke High-tech Co. Ltd. (China)
10. Spectrum Dynamics Medical Ltd. (Israel)
Advancements in imaging precision and diagnostic capability are transforming the nuclear medicine equipment market. Enhanced radiopharmaceutical integration is improving treatment accuracy. Continuous technological progress is strengthening clinical imaging outcomes across the nuclear medicine equipment market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Mediso Ltd. (Hungary) | |||||||
| Neusoft Medical Systems Co. Ltd. (China) | |||||||
| Bracco Imaging S.p.A. (Italy) | |||||||
| CMR Naviscan Corporation (United States) | |||||||
| Shenzhen Anke High-tech Co. Ltd. (China) | |||||||
| Spectrum Dynamics Medical Ltd. (Israel). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| MedGenome | Mar-26 | MedGenome acquired a majority stake in Medcare Management Services Pvt. Ltd., an imaging provider specializing in nuclear medicine and radiology. This investment strategically integrates a network of advanced diagnostic imaging facilities into MedGenome’s operations, expanding the company’s footprint in the clinical delivery of specialized nuclear medicine and molecular diagnostic services. |
| GE HealthCare | Dec-25 | GE HealthCare deployed its MINItrace Magni cyclotron at the University of Szeged, marking the system's first global installation. This project establishes a critical regional radiopharmaceutical supply center, significantly advancing theranostic capabilities and infrastructure for nuclear medicine research and clinical applications in Hungary. |
| Mediso Ltd | Apr-22 | Mediso Ltd completed the acquisition of Bartec Technologies Ltd, a UK-based firm specializing in the supply, installation, and support of nuclear medicine and molecular imaging equipment and accessories. This strategic acquisition enhances Mediso's distribution capabilities and technical support infrastructure within the regional molecular imaging market. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Nuclear Medicine Equipment Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Ownership Model | Capital Purchase, Lease, Managed Equipment/Pay-Per-Use |
| Service Model | Equipment Sale with Warranty, Service Contract, Comprehensive Managed Service |
| Procedure Volume | Low-Volume Facilities, Medium-Volume Facilities, High-Volume Facilities |
Nuclear Medicine Equipment Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Radiopharmaceutical Supply Infrastructure Assessment |
|
| Hospital Capital Investment and Replacement Outlook |
|
| Installed Base Modernization Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the nuclear medicine equipment market generate?
What are the growth projections for the nuclear medicine equipment industry?
How are evolving healthcare needs influencing investment in nuclear medicine imaging systems?
Why are precision therapies increasing demand for advanced nuclear medicine technologies?
Why is SPECT the largest equipment type in the nuclear medicine equipment market?
Why are Diagnostic Imaging Centers the fastest-growing end-use segment in the nuclear medicine equipment market?
Why is North America the largest market for nuclear medicine equipment?
What factors are supporting nuclear medicine equipment market growth in Asia Pacific?
What are the prominent companies operating in the nuclear medicine equipment landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization